Document is current
Any future updates will be listed below
-
Authors
Auanassova, Akerke https://orcid.org/0000-0002-3952-1650
Jatuworapruk, Kanon https://orcid.org/0000-0002-9301-8941
Sarkar, Manali https://orcid.org/0000-0002-6732-2907
Yessirkepov, Marlen https://orcid.org/0000-0003-2511-6918
Mukhamediyarov, Maidan https://orcid.org/0000-0003-0153-3741
Traboco, Lisa https://orcid.org/0000-0002-1952-7879
Goel, Ashish https://orcid.org/0000-0001-8513-2624
Zimba, Olena https://orcid.org/0000-0002-4188-8486
Agarwal, Vikas https://orcid.org/0000-0002-4508-1233
Nikiphorou, Elena https://orcid.org/0000-0001-6847-3726
Gupta, Latika https://orcid.org/0000-0003-2753-2990
,
Bautista-Molano, Wilson
Edwards, Christopher
Sparks, Jeffery A.
Caballero-Uribe, Carlo Vinicio
de Hooge, Manouk
Lauper, Kim
Boyd, Peter
Harifi, Ghita
Shumnalieva, Russka
Berenbaum, Francis
Dey, Dzifa
Kerkhof, Peter
Carmona, Loreto
Tanaka, Yoshiya
Santos, Cristiana Sieiro
Yoshida, Tsuneyasu
Talreja, Taanya
Mühlensiepen, Felix
Stoilova, Stefka
Ndosi, Mwidimi
Xu, Chuanhui
- License Information
-
More Information
Article History
Received: 29 June 2025
Accepted: 15 September 2025
First Online: 23 October 2025
Declarations
:
: EN has received speaker honoraria/participated in advisory boards for Celltrion, Pfizer, Sanofi, Gilead, Galapagos, AbbVie, and Lilly,and holds research grants from Pfizer and Lilly unrelated to the manuscript. Rest of the authors have no conflict of interest relevant to this manuscript. The views and opinions expressed are solely those of the author and do not represent or reflect those of any affiliated institution. Ethical approval Ethical approval was obtained from the Local Ethics Committee at South Kazakhstan Medical Academy, protocol N8, 2022.
